3.31
0.91%
0.03
Handel nachbörslich:
3.28
-0.03
-0.91%
Finanzdaten der Envveno Medical Corporation-Aktie (NVNO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
25.66%
2.451
|
3.297 | 2.551 | 2.60 | 3.202 |
Depreciation and Amortization |
0.00%
0.055
|
0.055 | 0.056 | 0.055 | 0.054 |
Operating Income/Loss |
12.34%
-5.503
|
-6.278 | -5.349 | -6.814 | -6.797 |
Nonoperating Income/Loss |
18.76%
0.511
|
0.629 | 0.348 | 0.34 | 0.405 |
Income/Loss From Continuing Operations Before Tax |
11.63%
-4.992
|
-5.649 | -5.001 | -6.474 | -6.392 |
Income/Loss From Continuing Operations After Tax |
11.63%
-4.992
|
-5.649 | -5.001 | -6.474 | -6.392 |
Net Income/Loss
|
11.63%
-4.992
|
-5.649 | -5.001 | -6.474 | -6.392 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,401%
16.06
|
1.07 | 11.23 | 11.23 | 11.23 |
Diluted Average Shares |
1,401%
16.06
|
1.07 | 11.23 | 11.23 | - |
Basic Earnings Per Share |
3.12%
-0.31
|
-0.32 | -0.45 | -0.58 | -0.57 |
Diluted Earnings Per Share |
3.12%
-0.31
|
-0.32 | -0.45 | -0.58 | -0.57 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):